drugset / Trial / NCT01005433
Dexmedetomidine for Cesarean Delivery
RandomizedParallel-groupDouble-blindPrevention
Summary
Regional anesthesia has become the anesthetic of choice for cesarean section in most countries; however, some women still prefer general anesthesia techniques. There are many trials for the pharmacological modifications of the sympathetic response to surgery, including opioids, tenoxicam, ketorolac, lidocaine and paracetamol. However, opioid administration to the mother before delivery has adverse neonatal effects. This research is a novel trial on the use of dexmedetomidine for suppression of the hemodynamic and hormonal responses of cesarean delivery.
Timeline
- Start
- 2009-12
- Primary completion
- 2011-10
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dexmedetomidine | Other / unclassified | 0.2 ug/kg | Intravenous |
| Comparator | Dexmedetomidine | Other / unclassified | 0.4 ug/kg | Intravenous |
| Comparator | Dexmedetomidine | Other / unclassified | 0.6 ug/kg | Intravenous |
Indications
No indication recorded.